Biosimilar BPCIA Patent Litigation: Section 337 Complaint Before the Trade Commission
A Section 337 complaint seeking exclusion of infringing imports in a Biosimilar BPCIA Patent Litigation matter.
The commission moves on a fixed and very fast schedule, and the domestic industry showing must be complete at filing. Includes the exhibits and the public interest statement. Prepared by an MC Law attorney and reviewed before delivery.
Frequently asked questions
The fee covers the finished document, filing-ready or send-ready as applicable, the supporting exhibits or attachments described in the scope, and a short cover memorandum explaining the choices made. It is fixed at this scope: one complaint, and excludes filing costs. 2 rounds of revisions are included. If your matter falls outside that scope we tell you before starting and quote the difference — we do not bill past a flat fee without agreeing it first.
5 to 8 weeks from a complete set of instructions, plus time for the 2 rounds of revisions included in the fee. If you are working to a court deadline or a closing date, tell us when you order and we will confirm in writing whether we can meet it before you commit.
$66,300 is $325/hour × 204 hours — the time this deliverable takes in an ordinary biosimilar bpcia patent litigation matter, at the firm's standard rate. Because it is a flat fee, the risk of the work running long sits with the firm: you pay $66,300 whether it takes us the estimate or twice it.
Third-party costs are never inside a flat fee and are passed through at cost, never marked up: court and agency filing fees, court reporter and transcript charges, expert witness fees, search vendor and e-discovery hosting charges, process server fees, and travel.
A short description of the dispute and where it currently stands, the key documents, contracts, and correspondence, the parties involved and any deadlines already running, and the case caption and court, if a matter has been filed. Send what you have — if something is missing we will tell you what else we need before the turnaround clock starts.
Clients also order
Other Biosimilar BPCIA Patent Litigation work MC Law prepares on a flat fee.
Biosimilar BPCIA Patent Litigation: Motion for Summary Judgment — Full Package
The complete summary judgment package in a Biosimilar BPCIA Patent Litigation case: notice, memorandum, separate statement of undisputed facts, evidentiary declaration with exhibits, and proposed order.
Biosimilar BPCIA Patent Litigation: Claim Construction Opening Brief
An opening claim construction brief in a Biosimilar BPCIA Patent Litigation case, arguing the intrinsic record first and the extrinsic evidence only where it helps.
Biosimilar BPCIA Patent Litigation: Claim Construction Responsive Brief
A responsive claim construction brief in a Biosimilar BPCIA Patent Litigation case, answering the opposing constructions and defending your own.
Biosimilar BPCIA Patent Litigation: Invalidity Contentions and Prior Art Charts
Invalidity contentions with prior art charts and the statutory grounds asserted for each reference in a Biosimilar BPCIA Patent Litigation case.
Biosimilar BPCIA Patent Litigation: Infringement Contentions and Claim Charts
Infringement contentions with element-by-element claim charts for a Biosimilar BPCIA Patent Litigation case.
Biosimilar BPCIA Patent Litigation: Markman Hearing Preparation and Technology Tutorial
Preparation for a claim construction hearing in a Biosimilar BPCIA Patent Litigation case, including a technology tutorial the judge can actually follow and a term-by-term argument outline.